Oral Abstract Session 11: Urticaria and Angioedema

Monday, 5 December 2011: 12:45 - 14:15
Costa Maya 2 (Cancún Center)
Chairpersons:   David Lang (US) and Jonathan Bernstein (US)
12:45 - 13:00
2214: The Efficacy of Human Plasma-Derived C1-Inhibitor Concentrate Used for Prophylactic Treatment In Patients with Hereditary Angioedema Due to C1-Inhibitor Deficiency | Dorottya Csuka (Hungary)
13:00 - 13:15
2215: Pre-Procedural Administration of Nanofiltered C1 Esterase Inhibitor (Human) (C1 INH-nf) for the Prevention of Hereditary Angioedema (HAE) Attacks After Medical, Dental, or Surgical Procedures David Mariano (US)
13:15 - 13:30
2216: Open-Label Use of Nanofiltered C1 Esterase Inhibitor (Human) (C1 INH-nf) for the Treatment of Hereditary Angioedema (HAE) Attacks Marc Riedl (US)
13:30 - 13:45
2217: Treatment of Acquired Angioedema with the Bradykinin Receptor Antagonist Icatibant | Maria Concetta Siani (Italy)
13:45 - 14:00
2218: Early Versus Delayed Treatment of Swelling Attacks with Icatibant, a Bradykinin 2 Receptor Antagonist, in Patients with Hereditary Angioedema Due to C1-INH Deficiency | Konrad Bork (Germany)
14:00 - 14:15
2219: Assessment of Chronic Spontaneous Urticaria by Serum-Induced TNFα and MMP-9 Release | Sidsel Falkencrone (Denmark)
See more of: Oral Abstract Session
See more of: Abstract Presentations
<< Previous Session | Next Session >>